Cargando…

Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs

Detalles Bibliográficos
Autores principales:	Tonali, Nicoló, Nencetti, Susanna, Orlandini, Elisabetta, Ciccone, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323684/ https://www.ncbi.nlm.nih.gov/pubmed/33433479 http://dx.doi.org/10.4103/1673-5374.303017

Ejemplares similares

Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design
por: Ciccone, Lidia, et al.
Publicado: (2020)

Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis
por: Ciccone, Lidia, et al.
Publicado: (2023)

The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
por: Ciccone, Lidia, et al.
Publicado: (2020)

Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2023)

Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2021)

New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2023)

Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction
por: Ciccone, Lidia, et al.
Publicado: (2021)

Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives
por: Ciccone, Lidia, et al.
Publicado: (2021)

Multifunctional Small Molecules as Potential Anti-Alzheimer’s Disease Agents
por: Bargagna, Beatrice, et al.
Publicado: (2021)

Copper mediated amyloid-β binding to Transthyretin
por: Ciccone, Lidia, et al.
Publicado: (2018)

Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators
por: Nocentini, Alessio, et al.
Publicado: (2020)

Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020)

Resveratrol-like Compounds as SIRT1 Activators
por: Ciccone, Lidia, et al.
Publicado: (2022)

Mapping the energy landscape of PROTAC-mediated protein-protein interactions
por: Villegas, José A., et al.
Publicado: (2023)

Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications
por: Ciccone, Lidia, et al.
Publicado: (2022)

Recent Advances in PROTACs for Drug Targeted Protein Research
por: Yao, Tingting, et al.
Publicado: (2022)

PROTAC: targeted drug strategy. Principles and limitations
por: Koroleva, O. A., et al.
Publicado: (2022)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021)

Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity
por: D'Andrea, Felicia, et al.
Publicado: (2020)

Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress
por: Ciccone, Lidia, et al.
Publicado: (2022)

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
por: Ishida, Tasuku, et al.
Publicado: (2020)

The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
por: Jin, Jinmei, et al.
Publicado: (2020)

PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
por: Sincere, Nuwayo Ishimwe, et al.
Publicado: (2023)

Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021)

Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway
por: Montalesi, Emiliano, et al.
Publicado: (2023)

PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
por: Guardigni, Melissa, et al.
Publicado: (2023)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

PROTACs: A novel strategy for cancer drug discovery and development
por: Han, Xin, et al.
Publicado: (2023)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
por: Mancarella, Caterina, et al.
Publicado: (2023)

The PROTAC technology in drug development
por: Zou, Yutian, et al.
Publicado: (2019)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

RNA‐PROTACs: Degraders of RNA‐Binding Proteins
por: Ghidini, Alice, et al.
Publicado: (2020)

PROTAC targeted protein degraders: the past is prologue
por: Békés, Miklós, et al.
Publicado: (2022)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
por: Ishikawa, Minoru, et al.
Publicado: (2020)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
por: Nencetti, Susanna, et al.
Publicado: (2020)

Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer’s Disease Therapy
por: Wostyn, Peter, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_01r7rhf0apkn3d2hp4au4mth66